339 related articles for article (PubMed ID: 1835792)
1. Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
Sakamoto H; Michaelson J; Jones WK; Bhan AK; Abhyankar S; Silverstein M; Golan DE; Burakoff SJ; Ferrara JL
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10890-4. PubMed ID: 1835792
[TBL] [Abstract][Full Text] [Related]
2. Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation.
Takata M; Imai T; Hirone T
J Clin Pathol; 1993 Sep; 46(9):801-5. PubMed ID: 7693765
[TBL] [Abstract][Full Text] [Related]
3. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
[TBL] [Abstract][Full Text] [Related]
4. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
Schneider MK; Grönvik KO
Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
[TBL] [Abstract][Full Text] [Related]
5. Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro.
Petrie HT; Hugo P; Scollay R; Shortman K
J Exp Med; 1990 Dec; 172(6):1583-8. PubMed ID: 2147945
[TBL] [Abstract][Full Text] [Related]
6. Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Gonin R; Murray C; Robertson MJ; Cochran K; Chartier S; Cameron C; Daley J; Levine H; Nadler LM
Blood; 1993 Oct; 82(7):2216-23. PubMed ID: 7691252
[TBL] [Abstract][Full Text] [Related]
7. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.
Abraham VS; Sachs DH; Sykes M
J Immunol; 1992 Jun; 148(12):3746-52. PubMed ID: 1534824
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of early graft-versus-host disease--a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients.
Sviland L; Pearson AD; Green MA; Baker BD; Eastham EJ; Reid MM; Hamilton PJ; Proctor SJ; Malcolm AJ
Transplantation; 1991 Dec; 52(6):1029-36. PubMed ID: 1836284
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease.
Fischer AC; Laulis MK; Horwitz L; Hess AD
Transplantation; 1991 Jan; 51(1):252-9. PubMed ID: 1898996
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
Truitt RL; Atasoylu AA
Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
[TBL] [Abstract][Full Text] [Related]
13. Selective reduction and proliferation of the CD4+ and CD8+ T cell subsets with bispecific monoclonal antibodies: evidence for inter-T cell-mediated cytolysis.
Wong JT; Colvin RB
Clin Immunol Immunopathol; 1991 Feb; 58(2):236-50. PubMed ID: 1824687
[TBL] [Abstract][Full Text] [Related]
14. Evidence for extrathymic development of TNK cells. NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice.
Kikly K; Dennert G
J Immunol; 1992 Jul; 149(2):403-12. PubMed ID: 1385604
[TBL] [Abstract][Full Text] [Related]
15. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation.
Weerasinghe A; Kawamura T; Moroda T; Seki S; Watanabe H; Abo T
Cell Immunol; 1998 Apr; 185(1):14-29. PubMed ID: 9636679
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
Hess AD; Horwitz LR; Laulis MK; Fuchs E
Clin Immunol Immunopathol; 1993 Dec; 69(3):341-50. PubMed ID: 7694818
[TBL] [Abstract][Full Text] [Related]
17. CD45RA antibodies split the CD3bright T cell subset.
Ezine S; Marvel J; Lightstone E; Dautigny N; Boitard C
Int Immunol; 1991 Sep; 3(9):917-22. PubMed ID: 1834164
[TBL] [Abstract][Full Text] [Related]
18. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
Tscherning T; Rudolphi A; Reimann J; Claesson MH
Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
[TBL] [Abstract][Full Text] [Related]
19. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
[TBL] [Abstract][Full Text] [Related]
20. Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease.
Murphy GF; Sueki H; Teuscher C; Whitaker D; Korngold R
J Invest Dermatol; 1994 Apr; 102(4):451-61. PubMed ID: 7908682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
